AR077410A1 - Metodo de cicatrizacion de heridas y modulacion de cicatrices - Google Patents
Metodo de cicatrizacion de heridas y modulacion de cicatricesInfo
- Publication number
- AR077410A1 AR077410A1 ARP100102522A ARP100102522A AR077410A1 AR 077410 A1 AR077410 A1 AR 077410A1 AR P100102522 A ARP100102522 A AR P100102522A AR P100102522 A ARP100102522 A AR P100102522A AR 077410 A1 AR077410 A1 AR 077410A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- dimethicone
- cross polymer
- scars
- modulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22440809P | 2009-07-09 | 2009-07-09 | |
| US22621609P | 2009-07-16 | 2009-07-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR077410A1 true AR077410A1 (es) | 2011-08-24 |
Family
ID=43427950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100102522A AR077410A1 (es) | 2009-07-09 | 2010-07-12 | Metodo de cicatrizacion de heridas y modulacion de cicatrices |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20110009374A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2451280A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2012532889A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102480969A (cg-RX-API-DMAC7.html) |
| AR (1) | AR077410A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010271205A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112012001098A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2767661A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2012000434A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011006100A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100322875A1 (en) | 2009-06-18 | 2010-12-23 | Advanced Bio-Technologies, Inc. | Silicone scar treatment preparation |
| US8623040B2 (en) | 2009-07-01 | 2014-01-07 | Alcon Research, Ltd. | Phacoemulsification hook tip |
| WO2012012390A1 (en) | 2010-07-19 | 2012-01-26 | Marvphyt Development Llc | Botanical composition and methods of manufacture and use |
| US10258505B2 (en) | 2010-09-17 | 2019-04-16 | Alcon Research, Ltd. | Balanced phacoemulsification tip |
| ITMI20111050A1 (it) * | 2011-06-10 | 2012-12-11 | Sevecom Spa | Uso di emulsionanti in associazione con oleine vegetali in un alimento per animali. |
| CN103648483A (zh) | 2011-06-24 | 2014-03-19 | 莫茨制药有限及两合公司 | 包含洋葱提取物和脂质体的组合物 |
| US9364510B2 (en) | 2011-07-19 | 2016-06-14 | Marvphyt Development Llc | Botanical composition and methods of manufacture and use |
| LT2736887T (lt) | 2011-07-29 | 2018-02-12 | Karyopharm Therapeutics, Inc. | Hidrazidą turintys branduolių transporto moduliatoriai ir jų panaudojimas |
| WO2013040265A1 (en) * | 2011-09-13 | 2013-03-21 | Brigham Young University Technology Commercialization Office | Compositions for treating bone diseases and broken bones |
| US9474685B2 (en) | 2011-09-28 | 2016-10-25 | Sure-Shot Medical Device Inc. | Apparatus for localized dermatological treatment |
| GB201120724D0 (en) * | 2011-12-01 | 2012-01-11 | Gauthier Rene | System and method for alleviating the appearance of scars and/or scar tissue |
| FR2985064B1 (fr) * | 2011-12-23 | 2016-02-26 | Oreal | Procede pour delivrer un conseil cosmetique |
| JP6093007B2 (ja) * | 2012-04-27 | 2017-03-08 | ダウ コーニング コーポレーションＤｏｗ Ｃｏｒｎｉｎｇ Ｃｏｒｐｏｒａｔｉｏｎ | 基質に有効成分を送達するためのシリコーン系賦形剤を含有する局所用製剤組成物 |
| HUE040427T2 (hu) | 2012-05-09 | 2019-03-28 | Biogen Ma Inc | Nukleáris transzportmodulátorok és felhasználásuk |
| US11458199B2 (en) * | 2012-08-21 | 2022-10-04 | Opko Pharmaceuticals, Llc | Liposome formulations |
| US9808654B2 (en) * | 2013-02-11 | 2017-11-07 | Jan Marini Skin Research | Post procedure skin care gel and methods of use thereof |
| EP2968278B8 (en) * | 2013-03-15 | 2019-05-22 | Karyopharm Therapeutics Inc. | Methods of promoting wound healing using crm1 inhibitors |
| CN105122261B (zh) * | 2013-04-23 | 2020-04-24 | 惠普发展公司，有限责任合伙企业 | 从遭到破坏的系统启动代码中恢复的方法以及计算装置 |
| EP3492455B1 (en) | 2013-06-21 | 2023-05-17 | Karyopharm Therapeutics Inc. | 1,2,4-triazoles as nuclear transport modulators and use in the treatment of specific forms of cancer |
| US11432990B2 (en) | 2013-08-30 | 2022-09-06 | ISOS Solutions, LLC | Textured apparatus with therapeutic material incorporated therein and methods of manufacturing same |
| US9226890B1 (en) | 2013-12-10 | 2016-01-05 | Englewood Lab, Llc | Polysilicone base for scar treatment |
| EP3087495A4 (en) * | 2013-12-23 | 2017-08-23 | Intel Corporation | Integrated component interconnect |
| JP7017311B2 (ja) | 2014-06-09 | 2022-02-08 | 広東科洛克生物医薬集団有限公司 | シリコンベースの生体光組成物およびその使用 |
| MA40433A (fr) | 2014-07-21 | 2017-06-14 | Sevecom Spa | Émulsion en poudre pour aliments pour animaux |
| EA201790384A1 (ru) | 2014-08-15 | 2017-08-31 | Кариофарм Терапевтикс, Инк. | Полиморфы селинексора |
| MA43529A (fr) | 2015-12-31 | 2018-11-07 | Karyopharm Therapeutics Inc | Modulateurs de transport nucléaire et leurs utilisations |
| WO2017117535A1 (en) | 2015-12-31 | 2017-07-06 | Karyopharm Therapeutics Inc. | Nuclear transport modulators and uses thereof |
| WO2018098472A1 (en) | 2016-11-28 | 2018-05-31 | Karyopharm Therapeutics Inc. | Crm1 inhibitors for treating epilepsy |
| JP7595413B2 (ja) | 2016-11-30 | 2024-12-06 | ケース ウエスタン リザーブ ユニバーシティ | １５－ｐｇｄｈ阻害剤とコルチコステロイドおよび／またはｔｎｆ阻害剤との組み合わせならびにその使用 |
| EP3576737A4 (en) | 2017-02-06 | 2021-04-21 | Case Western Reserve University | COMPOSITIONS AND METHODS OF MODULATING THE ACTIVITY OF SHORT CHAIN DEHYDROGENASE |
| CA3114363A1 (en) * | 2018-09-28 | 2020-04-02 | Joel Studin | Transpore delivery of steroids and large molecules |
| EP3883577A4 (en) | 2018-11-21 | 2022-06-15 | Case Western Reserve University | COMPOSITIONS AND METHODS FOR MODULATION OF SHORT CHAIN DEHYDROGENASE ACTIVITY |
| US20200397720A1 (en) * | 2019-06-23 | 2020-12-24 | Charles Huntington Gallina | Method and formulation for treatment of wounds by new tissue regeneration with reduced trauma and scar tissue formation |
| CN110368498A (zh) * | 2019-08-26 | 2019-10-25 | 瑞希(重庆)生物科技有限公司 | 一种促进伤口愈合的制剂及其制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6337076B1 (en) * | 1999-11-17 | 2002-01-08 | Sg Licensing Corporation | Method and composition for the treatment of scars |
| KR100362924B1 (ko) * | 2000-01-11 | 2002-11-30 | 주식회사 동구약품 | 외피용약제 조성물 |
| CN1443062A (zh) * | 2000-05-23 | 2003-09-17 | 荷兰联合利华有限公司 | 除臭剂和/或防汗剂组合物 |
| GB0018466D0 (en) * | 2000-07-27 | 2000-09-13 | Strakan Pharm Ltd | Keloid Treatment |
| US6610322B1 (en) * | 2000-12-20 | 2003-08-26 | Brian Charles Keller | Self forming, thermodynamically stable liposomes and their applications |
| US6495596B1 (en) * | 2001-03-23 | 2002-12-17 | Biozibe Laboratories, Inc. | Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase-2 |
| US6998421B2 (en) * | 2001-06-07 | 2006-02-14 | Biozone Laboratories, Inc. | Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase - 2 |
| JP4450545B2 (ja) * | 2001-07-05 | 2010-04-14 | ロート製薬株式会社 | エアゾール製剤 |
| JP4549006B2 (ja) * | 2002-05-07 | 2010-09-22 | ロート製薬株式会社 | ゲル軟膏 |
| GB0216427D0 (en) * | 2002-07-16 | 2002-08-21 | Advanced Biotechnologies Inter | Wound dressing |
| US20040220155A1 (en) * | 2003-03-28 | 2004-11-04 | Pharmacia Corporation | Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith |
| WO2005009342A2 (en) * | 2003-07-16 | 2005-02-03 | Pharmacia Corporation | Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith |
| WO2005123092A1 (en) * | 2004-06-17 | 2005-12-29 | Galderma S.A. | Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof |
| KR20080016612A (ko) * | 2005-06-10 | 2008-02-21 | 갈데르마 소시에떼아노님 | 약물, 필름형성 실리콘 및 하나 이상의 휘발성 용매를포함하는 국소조성물을 기초로 하는 피부를 통한 약물의조절된 방출 |
| CN103480026A (zh) * | 2007-03-08 | 2014-01-01 | 莫科治疗有限公司 | 一种疤痕敷料制剂 |
| US20080317830A1 (en) * | 2007-06-25 | 2008-12-25 | Liolabs Llc | Compositions and Methods for the Treatment of Wounds and Scar Tissue |
| DE102009030931A1 (de) * | 2009-06-24 | 2010-12-30 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Chirurgisches Wundverschlusselement |
-
2010
- 2010-07-09 MX MX2012000434A patent/MX2012000434A/es not_active Application Discontinuation
- 2010-07-09 CA CA2767661A patent/CA2767661A1/en not_active Abandoned
- 2010-07-09 CN CN2010800392366A patent/CN102480969A/zh active Pending
- 2010-07-09 JP JP2012519777A patent/JP2012532889A/ja active Pending
- 2010-07-09 EP EP10797937A patent/EP2451280A4/en not_active Withdrawn
- 2010-07-09 WO PCT/US2010/041576 patent/WO2011006100A1/en not_active Ceased
- 2010-07-09 BR BRBR112012001098-0A patent/BR112012001098A2/pt not_active IP Right Cessation
- 2010-07-09 AU AU2010271205A patent/AU2010271205A1/en not_active Abandoned
- 2010-07-09 US US12/833,902 patent/US20110009374A1/en not_active Abandoned
- 2010-07-12 AR ARP100102522A patent/AR077410A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2451280A1 (en) | 2012-05-16 |
| BR112012001098A2 (pt) | 2015-09-01 |
| AU2010271205A1 (en) | 2012-02-09 |
| CN102480969A (zh) | 2012-05-30 |
| CA2767661A1 (en) | 2011-01-13 |
| EP2451280A4 (en) | 2012-12-26 |
| WO2011006100A1 (en) | 2011-01-13 |
| MX2012000434A (es) | 2012-04-11 |
| JP2012532889A (ja) | 2012-12-20 |
| US20110009374A1 (en) | 2011-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR077410A1 (es) | Metodo de cicatrizacion de heridas y modulacion de cicatrices | |
| BRPI0809164B8 (pt) | Composição para administração tópica e composição farmacêutica compreendendo a referida composição | |
| JP2012532889A5 (cg-RX-API-DMAC7.html) | ||
| BR112012023421A2 (pt) | composição farmacêutica para tratamento de aumento de pressão intraocular | |
| CL2023000921A1 (es) | Derivados de 1,2,3,4-tetrahidroquinolina como inhibidores de la activacion de yap/taz-tead | |
| BR112013026494A2 (pt) | composto, composição farmacêutica, método para tratar condição | |
| UA111162C2 (uk) | Ін'єкційна композиція ацетоніду триамцинолону для лікування болю | |
| BR112012006686B8 (pt) | compostos de amida substituída, composições farmacêuticas contendo os ditos compostos, e uso dos mesmos para prevenir e/ou tratar doenças causadas pelo lpa | |
| BRPI0507198A (pt) | derivados de bisariluréia | |
| BR112015014585A2 (pt) | composto, composição farmacêutica, e, método de tratamento de um ser humano | |
| Georgiev et al. | Comparison of topical and intravenous administration of tranexamic acid for blood loss control during total joint replacement: Review of literature | |
| BR112015022588A2 (pt) | composto, composição farmacêutica, e, método para tratamento de imunossupressão em um indivíduo | |
| BR112014010542A2 (pt) | métodos e composições para tratamento de ferimento | |
| BRPI0923362B8 (pt) | método de produção de uma composição de liberação controlada de fosfato de ácido ascórbico, composição de liberação controlada e dispositivo médico. | |
| BR112013003847A2 (pt) | métodos de tratar a deterioração cognitiva moderada (mci) e os distúrbios relacionados | |
| BR112014013682B8 (pt) | composição para cuidado pessoal | |
| BR112012032076A2 (pt) | composição farmacêutica, e, métodos para tratar um paciente que está sofrendo de um distúrbio e de uma doença neurodegenerativa | |
| BR112013021566A2 (pt) | composto de fórmula, ou um aduto ou sal farmaceuticamente aceitável do mesmo e método de prevenção e/ou tratamento de um indivíduo que compreende a administração ao dito indivíduo uma quantidade terapeuticamente eficaz de um composto de fórmula | |
| BR112022021640A2 (pt) | Usos e formulações de canabinoides | |
| BR112012017476A2 (pt) | composto, composição, método para preparar uma composição, uso de um composto, e, métodos para tratar doenças, para inibir um alérgico peptidase do ácaro da poeira, para exterminar ácaros, para controlar uma população de ácaros | |
| AR074309A1 (es) | Compuestos anti-inflamatorios y sus composiciones farmaceuticas, dentifricas y adhesivas. metodo | |
| BR112015001627A2 (pt) | composição farmacêutica, respectivos usos e método para diminuir a frequência de micção | |
| BR112015001006A2 (pt) | composições farmacêuticas contendo ácido lático oligomérico | |
| BR112017025189A2 (pt) | composição e usos da mesma | |
| BR112018072379A2 (pt) | composição de filtro solar e método para proporcionar benefício para cuidados da pele |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |